• 00:00    |    
    Initial credits
  • 00:20    |    
  • 01:52    |    
    Calcifying nanoparticles
  • 02:52    |    
    • Evolution process
    • Childhood incidence
    • Teenage incidence
    • Late diagnosis
    • Silent disease
    • Causes
    • Histopathology
    • Bibliographical publications
    • LDL levels
    • Inflammatory response
    • Effects of microbial agents
    • Indirect effects of infectious agents
    • Clinical trials
    • Plaque development
    • Apoptosis
    • Helicobacter pylori
    • Pathological calicifications
  • 18:14    |    
    • Calcifying nanoparticles
    • Size of particles
    • Characteristics
    • Cytotoxicity
    • Abnormal and reversible calcification
    • Vaccine contamination
    • Cardiovascular disease
    • Particle structure
    • Nanobacterium in the heart
    • Nanobacterium behavior video
  • 26:14    |    
    Cardiology studies
    • Score intervention study
    • Patient profiles
    • Cardiology trial results
    • Limitations of the study
    • Conclusions
    • Calcium pre-eminence
    • Role of nanoparticles
  • 34:39    |    
    Question and answer period
    • How do nanoparticles reproduce?
    • What is the correlation of calcium score levels and family history?
    • Did you measure nanobacterium levels in children?
    • Chelation related to calcium score levels
  • 43:03    |    
    Final words
  • 43:26    |    
    Final credits

Nanobacterium Sanguineum

New Media  | 28 de enero de 2010  | Vistas: 238

Advances in the medical world have enabled professionals in this area to improve the capability of investigation and analysis of previously unknown health issues. In this conference, Benedict S. Maniscalco elaborates on a very important disease that affects almost every human being: atherosclerosis. He explains how this disease enters the body, and shares what its symptoms, main characteristics, and problem diagnosis are. He also describes how recently discovered calcifying nanoparticles have a great incidence in the evolution of atherosclerosis, as well as how it affects the cardiovascular system. Through many clinical studies, Maniscalco has been able to identify the source of this problem and the efficient ways to prevent its appearance and progression.


Benedict S. Maniscalco is a specialist in cardiovascular disease. He is…


Nuestra misión es la enseñanza y difusión de los principios éticos, jurídicos y económicos de una sociedad de personas libres y responsables.

Universidad Francisco Marroquín